Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 326.50
Bid: 325.00
Ask: 326.00
Change: 3.50 (1.08%)
Spread: 1.00 (0.308%)
Open: 328.50
High: 329.50
Low: 322.50
Prev. Close: 323.00
MGAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q3 Trading Update

9 Nov 2023 07:00

RNS Number : 8547S
Morgan Advanced Materials PLC
09 November 2023
 

 

 

Press Release

Morgan Advanced Materials plc

9 November 2023

 

Trading Update

Strong financial position, growth outlook unchanged

Morgan Advanced Materials plc, the global manufacturer of advanced carbon and ceramic materials for technically demanding applications, announces today its scheduled trading update for the first nine months to 30 September 2023.

Current Trading

Sales for the nine months to September 2023 were 2.4% higher for the Group, on an organic constant-currency basis, compared with the same period last year. Our recovery from the cyber incident we experienced at the start of the year has progressed as planned. By business unit, organic constant-currency sales performance for the nine months to September 2023, compared with the same period last year, were as follows:

 

Thermal Ceramics

+0.9%

Molten Metal Systems

-7.2%

Electrical Carbon

+6.5%

Seals and Bearings

-5.4%

Technical Ceramics

+7.7%

 

Outlook

Our outlook for full year organic revenue growth is unchanged at 2-4%. The group has continued to benefit from strong growth in its Semiconductor, Healthcare and Aerospace end-markets, offsetting weakness in European and China industrial markets. Seals & Bearings performance was influenced in part by phasing of armour orders.

Margins have continued to improve sequentially, despite an adverse movement in FX impacting the second half by circa £3m.

We continue to pursue opportunities to remove cost to ensure we enter 2024 with the right cost structure. Although uncertainty remains around some of our end markets, looking forward we expect continued margin improvement and good growth in H1 2024, especially given the cyber incident in the comparative period. In particular, we expect sustained growth in Semiconductor driven by demand for Silicon Carbide applications in power electronics.

 

Pete Raby, Chief Executive Officer, said:

"Our business is growing as anticipated, benefitting from our leading, differentiated positions in selected markets and despite the challenging environment, with inflation continuing to be more than offset by pricing.

Our Board remains committed to our financial framework. Investment in capacity for our faster growing segments is accelerating, and we continue to investigate inorganic investments as well as consider opportunities for enhanced returns to shareholders."

The full year results are expected to be released on 14 March 2024. A Capital Markets Event will be held during Q2 2024, with updates on progress in our faster growing markets, opportunities for efficiency improvement and investment plans.

 

For further enquiries:

Pete Raby

Morgan Advanced Materials plc

01753 837000

Richard Armitage

Nina Coad

Brunswick

0207 404 5959

 

1. Company-compiled summary of current analysts' forecasts for adjusted operating profit for 2023 is a range of £120.5 million to £125.0 million.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAPFPEEDDFFA
Date   Source Headline
16th Dec 20151:26 pmRNSAdoption of FRS 101 - Reduced Disclosure Framework
15th Dec 20153:56 pmRNSHolding(s) in Company
15th Dec 20153:16 pmRNSBlocklisting Interim Review
2nd Dec 20159:10 amRNSHolding(s) in Company
26th Nov 201512:22 pmRNSDirector/PDMR Shareholding
24th Nov 20153:25 pmRNSHolding(s) in Company
13th Nov 201512:18 pmRNSDirector/PDMR Shareholding
12th Nov 20157:00 amRNSTrading Update
9th Oct 201511:14 amRNSHolding(s) in Company
2nd Oct 20157:00 amRNSBoard Change
29th Sep 20152:47 pmRNSDirector/PDMR Shareholding
25th Sep 201510:43 amRNSDirector Declaration
17th Sep 201511:50 amRNSHolding(s) in Company
11th Sep 201511:23 amRNSHolding(s) in Company
10th Sep 20153:21 pmRNSHolding(s) in Company
2nd Sep 20159:11 amRNSDirector/PDMR Shareholding
20th Aug 201512:07 pmRNSDirector/PDMR Shareholding
4th Aug 201510:13 amRNSDirector/PDMR Shareholding
22nd Jul 20157:00 amRNSHalf Yearly Results
2nd Jul 20155:22 pmRNSHolding(s) in Company
15th Jun 20153:53 pmRNSBlocklisting Interim Review
5th Jun 20153:29 pmRNS2014 Environmental, Health and Safety Report
28th May 201511:22 amRNSHolding(s) in Company
20th May 20157:00 amRNSTrading Update
8th May 20153:51 pmRNSResult of AGM
16th Apr 20154:14 pmRNSDirector/PDMR Shareholding
2nd Apr 20158:40 amRNSDirector/PDMR Shareholding
31st Mar 20153:18 pmRNSHolding(s) in Company
31st Mar 20153:14 pmRNSDirector/PDMR Shareholding
31st Mar 201510:12 amRNSPublication of 2014 Annual Report
27th Mar 20159:41 amRNSDirector/PDMR Shareholding
26th Mar 20152:37 pmRNSDirector/PDMR Shareholding
25th Mar 20152:33 pmRNSDirector/PDMR Shareholding
24th Mar 20151:42 pmRNSDirector/PDMR Shareholding
24th Mar 20151:36 pmRNSDirector/PDMR Shareholding
2nd Mar 201512:32 pmRNSDirector/PDMR Shareholding
26th Feb 20152:05 pmRNSDirector/PDMR Shareholding
12th Feb 20157:00 amRNSFY RESULTS FOR THE YEAR ENDED 31 DECEMBER 2014
30th Jan 20157:00 amRNSAppointment of Chief Executive Officer
23rd Dec 20142:03 pmRNSStatement under s.430 (2B) Companies Act 2006
23rd Dec 20142:00 pmRNSStatement under s. 430(2B) Companies Act 2006
18th Dec 201412:08 pmRNSHolding(s) in Company
18th Dec 201412:00 pmRNSDirector/PDMR Shareholding
16th Dec 201410:05 amRNSBlocklisting Interim Review
12th Dec 20141:05 pmRNSBoard Changes
3rd Dec 201410:47 amRNSDirector/PDMR Shareholding
1st Dec 20148:49 amRNSRejection of Vesuvius Proposal
1st Dec 20147:00 amRNSStatement of intention not to make an offer
11th Nov 20147:00 amRNSTrading Update
17th Oct 201410:17 amRNSMorgan Advanced Matereals - CDP Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.